دورية أكاديمية
Optimal Frequency to Screen Celiac Disease amongst Patients with Type 1 Diabetes Mellitus: A Multicenter Study.
| العنوان: | Optimal Frequency to Screen Celiac Disease amongst Patients with Type 1 Diabetes Mellitus: A Multicenter Study. |
|---|---|
| المؤلفون: | Moravej H; Neonatal Research Center, Shiraz University of Medical Sciences, Shiraz, Iran; Department of Pediatric Endocrinology and Metabolism, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran., Zamanfar D; Diabetes Research Center, Mazandaran University of Medical Sciences, Sari, Iran., Aghamahdi F; Department of Pediatric, Non-communicable Diseases Research Center, Alborz University of Medical Sciences, Karaj, Iran., Hashemipour M; Metabolic Liver Disease Research Center, Isfahan University of Medical Sciences, Isfahan, Iran., Mirrashidi FS; Department of Pediatric, Jiroft University of Medical Sciences, Jiroft, Iran., Ghaemi N; Department of Pediatric Endocrinology and Metabolism, Mashhad University of Medical Sciences, Mashhad, Iran., Eshraghi P; Department of Pediatric Endocrinology and Metabolism, Mashhad University of Medical Sciences, Mashhad, Iran., Ilkhanipoor H; Department of Pediatric Endocrinology and Metabolism, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran. Electronic address: h_ilkhani66@yahoo.com., Amirhakimi A; Department of Pediatric Endocrinology and Metabolism, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran., Yazdani N; Neonatal Research Center, Shiraz University of Medical Sciences, Shiraz, Iran., Asl SN; Department of Pediatric Endocrinology and Metabolism, Mashhad University of Medical Sciences, Mashhad, Iran., Hashemian S; Department of Pediatric Diseases, Akbar Hospital, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran., Raoofat A; Department of Medical Genetics, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran., Vazirian MV; Pediatric Endocrinologist, Shafa Hospital, Kerman University of Medical Sciences, Kerman, Iran., Ebrahimzadeh H; Department of Pediatric Endocrinology and Metabolism, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran. |
| المصدر: | Primary care diabetes [Prim Care Diabetes] 2021 Dec; Vol. 15 (6), pp. 1100-1103. Date of Electronic Publication: 2021 Sep 06. |
| نوع المنشور: | Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't |
| اللغة: | English |
| بيانات الدورية: | Publisher: Elsevier Country of Publication: England NLM ID: 101463825 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-0210 (Electronic) Linking ISSN: 18780210 NLM ISO Abbreviation: Prim Care Diabetes Subsets: MEDLINE |
| أسماء مطبوعة: | Original Publication: Kidlington, Oxford : Elsevier |
| مواضيع طبية MeSH: | Celiac Disease*/diagnosis , Celiac Disease*/epidemiology , Diabetes Mellitus, Type 1*/diagnosis , Diabetes Mellitus, Type 1*/epidemiology, Humans ; Iran/epidemiology ; Referral and Consultation ; Retrospective Studies |
| مستخلص: | Aims: Celiac disease (CD) is frequent amongst patients with type 1 diabetes mellitus (T1DM). Since there is a disagreement on the optimal interval and frequency to perform screening tests for CD among diabetic patients, this study aimed to evaluate these issues amongst patients with T1DM. Methods: This retrospective cohort study was conducted in seven referral diabetic centers in different cities of Iran from January 2020 to January 2021. Data belonging to 106 patients who were affected by both T1DM and CD was collected. The time interval between CD diagnosis and diabetes (IBCD), the age of diabetes onset, and any associated diseases, symptoms, and family history of T1DM and CD were recorded and analyzed. Results: Results show that 45% of the patients with CD were diagnosed during the first year of diabetes onset; furthermore, 18% and 16% of the patients with CD were diagnosed in the second or third year after being diagnosed with diabetes. In addition, another 18% of patients with CD were diagnosed during the fourth till the eighth year after diabetes onset. Moreover, there was a negative relationship between the age of T1DM diagnosis and IBCD. Most participants were asymptomatic at the time of CD diagnosis. Conclusions: Screening tests to detect CD amongst patients with T1DM should continue for at least eight years after the initial T1DM diagnosis, especially those affected at a younger age. (Copyright © 2021 Primary Care Diabetes Europe. Published by Elsevier Ltd. All rights reserved.) |
| فهرسة مساهمة: | Keywords: Autoimmune Diseases; Celiac disease; Diabetes Mellitus; Transglutaminase; Type 1 |
| تواريخ الأحداث: | Date Created: 20210910 Date Completed: 20220131 Latest Revision: 20220131 |
| رمز التحديث: | 20221213 |
| DOI: | 10.1016/j.pcd.2021.08.011 |
| PMID: | 34503936 |
| قاعدة البيانات: | MEDLINE |
Full Text via ClinicalKey 
Full Text Finder | تدمد: | 1878-0210 |
|---|---|
| DOI: | 10.1016/j.pcd.2021.08.011 |